Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback